MANF

AcronymDefinition
MANFManifold
MANFMesencephalic Astrocyte-Derived Neurotrophic Factor (protein type)
MANFMake a Noise Foundation (Nashville, TN)
References in periodicals archive ?
MANF is in preclinical development for the treatment of orphan ophthalmological disorders, glaucoma and Parkinson's disease.
Biotechnology company Amarantus Bioscience Holdings (Other OTC:AMBS) reported on Friday the receipt of the Chinese patent entitled "Neurodegenerative Disorders" covering the use of MANF for the treatment of Parkinson's disease and other neurodegenerative conditions.
MANF is a naturally-occurring protein that reduces and prevents apoptosis (programmed cell death) in response to injury or disease.
En el grupo II el 80% de los MANF no presentaron remanente o tenian reseccion mayor al 75% (GI) versus el 64% en el grupo I, aunque esta diferencia no fue estadisticamente significativa.
MANF is released from glial cells in the midbrain and is a member of the same growth factor family as CDNF.
Therefore, TECH, MANF and IND became one of few global players in a highly specialized product.
According to the company, MANF is a naturally-occurring protein that reduces and prevents apoptosis (programmed cell death) in response to injury or disease.
13/305,025, will provide additional intellectual property protection for MANF (mesencephalic-astrocyte-derived neurotrophic factor) protein therapy and cell therapy.
The Opposition Division held that Hermo Phrama's arguments did not prejudice the maintenance of the patent as originally granted, with broad claims covering MANF and its derivatives.
According to the company, it owns composition of matter patents and various composition and method of use patent applications for MANF and derivative sequences for protein therapeutic, gene therapy and certain cell therapy applications worldwide.
Next up will be MANF, the groundbreaking new therapeutic protein that Amarantus is developing to treat Parkinson's disease and traumatic brain injuries.
M2 EQUITYBITES-June 23, 2014-Amarantus partners with Washington University School of MedicineJack to evaluate the efficacy of MANF to treat Wolfram disease